Alexander K. Arrow is Chief Financial Officer of Protagenic Therapeutics, Inc.new. Currently has a direct ownership of 45,815 shares of PTIXW, which is worth approximately $4,581. The most recent transaction as insider was on Oct 12, 2023, when has been sold 8,000 shares (PTIX Common Stock) at a price of $0.81 per share, resulting in proceeds of $6,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.8K
0% 3M change
0% 12M change
Total Value Held $4,581

Alexander K. Arrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2023
BUY
Open market or private purchase
$6,480 $0.81 p/Share
8,000 Added 14.87%
45,815 PTIX Common Stock
May 18 2022
BUY
Open market or private purchase
$5,760 $0.72 p/Share
8,000 Added 5.02%
151,260 PTIX Common Stock
May 17 2022
BUY
Open market or private purchase
$16,330 $0.71 p/Share
23,000 Added 13.83%
143,260 PTIX Common Stock
Apr 30 2021
BUY
Open market or private purchase
$2,290 $2.29 p/Share
1,000 Added 0.82%
120,260 PTIX Common Stock
Apr 29 2021
BUY
Open market or private purchase
$2,290 $2.29 p/Share
1,000 Added 0.83%
119,260 PTIX Common Stock
AKA

Alexander K. Arrow

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on PTIXW

Follow Protagenic Therapeutics, Inc.new and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTIXW shares.

Notify only if

Insider Trading

Get notified when an Protagenic Therapeutics, Inc.New insider buys or sells PTIXW shares.

Notify only if

News

Receive news related to Protagenic Therapeutics, Inc.new

Track Activities on PTIXW